These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9070868)

  • 1. 5'-Diphosphoadenosine 3'-phosphate is a potent inhibitor of bovine pancreatic ribonuclease A.
    Russo N; Shapiro R; Vallee BL
    Biochem Biophys Res Commun; 1997 Feb; 231(3):671-4. PubMed ID: 9070868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution.
    Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
    Biochemistry; 1997 May; 36(18):5578-88. PubMed ID: 9154942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
    Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
    Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decavanadate inhibits catalysis by ribonuclease A.
    Messmore JM; Raines RT
    Arch Biochem Biophys; 2000 Sep; 381(1):25-30. PubMed ID: 11019816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
    Kobe B; Deisenhofer J
    J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition of mammalian ribonucleases by 3', 5'-pyrophosphate-linked nucleotides.
    Russo N; Shapiro R
    J Biol Chem; 1999 May; 274(21):14902-8. PubMed ID: 10329690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected binding mode for 2'-phosphoadenosine-based nucleotide inhibitors in complex with human angiogenin revealed by heteronuclear NMR spectroscopy.
    Tonan K; Xu P; Jenkins JL; Russo A; Shapiro R; Ni F
    Biochemistry; 2003 Sep; 42(38):11137-49. PubMed ID: 14503864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward RNase inhibitors: thermodynamics of 2'-CMP/RNase-A binding in multi-ion buffer.
    Raffa RB; Spencer SD; Schulingkamp RJ
    Biochem Pharmacol; 2002 Jun; 63(11):1937-9. PubMed ID: 12093469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.
    Dossi K; Tsirkone VG; Hayes JM; Matousek J; Poucková P; Soucek J; Zadinova M; Zographos SE; Leonidas DD
    Eur J Med Chem; 2009 Nov; 44(11):4496-508. PubMed ID: 19643512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
    Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
    J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of ribonuclease A in complex with thymidine-3'-monophosphate provides further insight into ligand binding.
    Doucet N; Jayasundera TB; Simonović M; Loria JP
    Proteins; 2010 Aug; 78(11):2459-68. PubMed ID: 20602460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coulombic effects of remote subsites on the active site of ribonuclease A.
    Fisher BM; Schultz LW; Raines RT
    Biochemistry; 1998 Dec; 37(50):17386-401. PubMed ID: 9860854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined kinetic and modeling study of the catalytic center subsites of human angiogenin.
    Russo N; Acharya KR; Vallee BL; Shapiro R
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):804-8. PubMed ID: 8570639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoside-amino acid conjugates: An alternative route to the design of ribonuclease A inhibitors.
    Debnath J; Dasgupta S; Pathak T
    Bioorg Med Chem; 2009 Jul; 17(14):4921-7. PubMed ID: 19540766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
    Leonidas DD; Chavali GB; Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Vlassi M; Frankling C; Acharya KR
    Protein Sci; 2003 Nov; 12(11):2559-74. PubMed ID: 14573867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoupling of melting domains in immobilized ribonuclease A.
    Rialdi G; Battistel E
    Proteins; 1994 Jun; 19(2):120-31. PubMed ID: 8090706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea polyphenols as inhibitors of ribonuclease A.
    Ghosh KS; Maiti TK; Dasgupta S
    Biochem Biophys Res Commun; 2004 Dec; 325(3):807-11. PubMed ID: 15541362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of IMP to ribonuclease A.
    Hatzopoulos GN; Leonidas DD; Kardakaris R; Kobe J; Oikonomakos NG
    FEBS J; 2005 Aug; 272(15):3988-4001. PubMed ID: 16045769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coulombic forces in protein-RNA interactions: binding and cleavage by ribonuclease A and variants at Lys7, Arg10, and Lys66.
    Fisher BM; Ha JH; Raines RT
    Biochemistry; 1998 Sep; 37(35):12121-32. PubMed ID: 9724524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.